Skip to main content
Deccan Health Care Limited logo

Deccan Health Care Limited — Investor Relations & Filings

Ticker · 542248 ISIN · INE452W01019 LEI · 335800GRFYZWB9Y2JG11 BSE.NS Manufacturing
Open in API
Filings indexed 397 across all filing types
Latest filing 2026-05-30 Audit Report / Informat…
Country IN India
Listing BSE.NS 542248

About Deccan Health Care Limited

https://www.deccanhealthcare.co.in/

Deccan Health Care Limited specializes in the development, manufacturing, and marketing of health and wellness products. The company focuses on nutraceuticals, cosmeceuticals, and therapeutic solutions designed to address nutritional deficiencies and promote preventive healthcare. Its product portfolio includes dietary supplements, vitamins, minerals, and herbal formulations available in various delivery formats such as tablets, capsules, powders, and liquids. The organization emphasizes research and development to create innovative formulations that cater to various life stages and health requirements. By leveraging advanced manufacturing processes and quality control standards, the company provides solutions aimed at enhancing overall well-being and managing lifestyle-related health conditions. Its operations encompass both proprietary brand development and contract manufacturing services.

Recent filings

Filing Released Lang Actions
Audited Standalone and Consolidated Financial results for the FY 2025-26.
Audit Report / Information Classification · 86% confidence The document is an SEBI LODR filing titled “Outcome of Board Meeting” which attaches the Standalone and Consolidated Audited Financial Results for the year ended March 31, 2026, along with an unmodified Auditor’s Report. It contains the full Independent Auditor’s Report and the audited financial statements. This is not a full annual report (10-K), nor simply a report‐publication notice. It is precisely a standalone audit report and audited results. Thus it best fits the Audit Report / Information category (AR). FY 2026
2026-05-30 English
Annual Results for the FY 2025-26 and Corporate Update
Earnings Release Classification · 91% confidence The document is a press release under SEBI (Listing Obligations) Regulation 30 announcing FY 2025–26 annual financial results and providing key financial highlights (revenue, PAT, EPS, growth rates) rather than containing full audited statements or being the formal annual report. It constitutes an initial announcement of periodical financial results with corporate updates, fitting the definition of an Earnings Release (ER). FY 2026
2026-05-30 English
Board of Directors of the Company, at its meeting held today i.e. Saturday, 30th May, 2026 which was commenced at 3:00 PM Via Video Conferencing, has inter alia considered and approved ....
Interim / Quarterly Report Classification · 85% confidence The document is the outcome of the Board meeting announcing and approving the Standalone and Consolidated Audited Financial Results for the quarter and year ended 31 March 2026, followed by the full Independent Auditor’s Report under SEBI LODR Regulation 33, and detailed financial statements with notes. It is a statutory quarterly/periodic financial disclosure containing actual financial data (audited results for Q4 and year to date) rather than a full annual report or mere announcement. This matches the definition of an Interim/Quarterly Report (IR). FY 2026
2026-05-30 English
Annual Secretarial Compliance Report for the FY 2025-26.
Regulatory Filings Classification · 87% confidence The document is a letter from Deccan Healthcare to the BSE submitting the Annual Secretarial Compliance Report for the year ended March 31, 2026, prepared by a practising company secretary under SEBI LODR regulations. It does not present full financial statements or quarterly results (so not IR/10-K), nor is it a proxy, AGM presentation, or management discussion. It is a compliance/certification filing under SEBI regulations, which falls under the general "Regulatory Filings" category (RNS) as a fallback for miscellaneous statutory filings that do not fit other specific categories.
2026-05-29 English
Deccan Health Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve Audited Financial Results ....
Regulatory Filings Classification · 92% confidence The document is a Board Meeting intimation sent to the stock exchange in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulation 29. It schedules a board meeting to approve audited financial results and reminds insiders about the trading window. It does not present financial results itself, nor is it a management change, proxy, dividend notice, or call transcript. It is a regulatory compliance announcement, best classified as a general regulatory filing (RNS).
2026-05-22 English
Intimation
Regulatory Filings
2026-04-30 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.